Jim Simons Enovis Corp Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$44.56 - $62.43 $3.38 Million - $4.74 Million	-75,900 Reduced 50.99%	72,967 $3.3 Million
Q1 2024 May 13, 2024	BUY	$55.44 - $63.8 $2.31 Million - $2.66 Million	41,700 Added 38.91%	148,867 $9.3 Million
Q4 2023 Feb 13, 2024	BUY	$43.67 - $57.07 $1.16 Million - $1.51 Million	26,500 Added 32.85%	107,167 $6 Million
Q3 2023 Nov 14, 2023	SELL	$51.65 - $65.54 $981,350 - $1.25 Million	-19,000 Reduced 19.06%	80,667 $4.25 Million
Q2 2023 Aug 11, 2023	SELL	$52.7 - $64.12 $711,450 - $865,620	-13,500 Reduced 11.93%	99,667 $6.39 Million
Q1 2023 May 12, 2023	BUY	$49.5 - $65.92 $5.09 Million - $6.78 Million	102,900 Added 1002.24%	113,167 $6.05 Million
Q4 2022 Feb 13, 2023	BUY	$44.83 - $57.43 $460,269 - $589,633	10,267 New	10,267 $549,000

310

60.2M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.41B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.